Volume 25, Number 9—September 2019
    
    Dispatch
Rickettsia japonica Infections in Humans, Xinyang, China, 2014–2017
Table
Laboratory test results of samples from 14 patients with Rickettsia japonica infection at different time points, China, 2014–2017
| Result | No. patients | ||
|---|---|---|---|
| At admission | During hospitalization | At discharge from hospital | |
| Anemia, <3.5 × 1012 erythrocytes/L | 0 | 5 | 3 | 
| Leukopenia, <4.0 × 109 leukocytes/L | 3 | 3 | 0 | 
| Thrombocytopenia, <150 × 109 platelets/L | 9 | 11 | 0 | 
| Hyperbilirubinemia, albumin >17.1 μmol/L | 4 | 5 | 2 | 
| Hypoalbuminemia, albumin <35.0 g/L | 3 | 9 | 7 | 
| Hyponatremia, sodium <135.0 mmol/L | 4 | 6 | 2 | 
| Hypopotassemia, potassium <3.5 mmol/L | 2 | 4 | 2 | 
| Increased ALT level, >0.67 μkat/L | 8 | 10 | 5 | 
| Increased AST level, >0.67 μkat/L | 10 | 12 | 5 | 
| Increased LDH level, >4.1 μkat/L | 10 | 11 | 7 | 
| Increased CK level, >4.1 μkat/L | 4 | 3 | 0 | 
*ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatine kinase; LDH, lactate dehydrogenase.
Page created: August 20, 2019
                            Page updated: August 20, 2019
                            Page reviewed: August 20, 2019
        
    The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
